About GeniPhys
GeniPhys is a company based in Zionsville (United States) founded in 2014. GeniPhys has raised $13.47 million across 7 funding rounds from investors including National Science Foundation, Pier 70 Ventures and Elevate Ventures. GeniPhys offers products and services including Collymer Technology. GeniPhys operates in a competitive market with competitors including Organogenesis, Sofregen, Collplant, BioTissue and Reapplix, among others.
- Headquarter Zionsville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Geniphys, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.47 M (USD)
in 7 rounds
-
Latest Funding Round
$3 M (USD), Series A
Jan 29, 2026
-
Investors
National Science Foundation
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeniPhys
GeniPhys offers a comprehensive portfolio of products and services, including Collymer Technology.
Polymerizable collagen for tissue regeneration and restoration applications.
People of GeniPhys
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Founder Team
1 people
Chairman Team
1 people
COO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of GeniPhys
GeniPhys has successfully raised a total of $13.47M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GeniPhys
GeniPhys has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation, Pier 70 Ventures and Elevate Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Locked | Locked | Locked | |
|
Support for technology commercialization and startup development is provided.
|
Locked | Locked | Locked |
Investor details for GeniPhys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GeniPhys
Investment portfolio details for GeniPhys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GeniPhys
Detailed financials for GeniPhys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Geniphys Comparisons
Peer comparison for GeniPhys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GeniPhys
GeniPhys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, Collplant, BioTissue and Reapplix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative therapies for wound care are developed and commercialized.
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of patch system for wound healing
|
|
| Locked | Locked | Locked |
Developer of regenerative materials
|
Detailed competitors of GeniPhys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Geniphys
Complete news archive for GeniPhys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GeniPhys
GeniPhys was founded in 2014 and raised its 1st funding round 1 year after it was founded.
GeniPhys is headquartered in Zionsville, United States. It is registered at Zionsville, Indiana, United States.
GeniPhys is a funded company, having raised a total of $13.47M across 7 funding rounds to date.
GeniPhys was founded in 2014 and is based in Zionsville, United States. Collagen polymers are developed within the biotechnology sector for tissue regeneration. Collymer, a polymerizable collagen-based scaffold, is provided to facilitate tissue restoration. This material is applied in areas such as cartilage replacement, vascular grafts, heart valve replacement, and related medical uses. Operations focus on advancing regenerative medicine solutions.
GeniPhys's top competitors include Organogenesis, Collplant and Acera Surgical.
GeniPhys offers Collymer Technology.
GeniPhys has 4 investors. Key investors include National Science Foundation, Pier 70 Ventures, Elevate Ventures, and Purdue Innovates.